Literature DB >> 19109316

Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis.

P Pasquetti, G Morozzi, M Galeazzi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109316     DOI: 10.1093/rheumatology/ken456

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

1.  [Psoriasis arthritis. An interdisciplinary challenge].

Authors:  M A Radtke; K Reich; F Beikert; M Augustin
Journal:  Hautarzt       Date:  2011-10       Impact factor: 0.751

2.  Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease?

Authors:  Rodolfo Perez-Alamino; Ignacio Garcia-Valladares; Raquel Cuchacovich; Antonio Iglesias-Gamarra; Luis R Espinoza
Journal:  Rheumatol Int       Date:  2014-02-11       Impact factor: 2.631

3.  Low Prevalence of Anti-cyclic Citrullinated Peptide Antibodies in Japanese Patients with Pustulotic Arthro-osteitis.

Authors:  Takenobu Ohashi; Tomoko Hiraiwa; Toshiyuki Yamamoto
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

4.  Anti-cyclic-citrullinated-protein-antibodies in psoriatic arthritis patients: how autoimmune dysregulation could affect clinical characteristics, retention rate of methotrexate monotherapy and first line biotechnological drug survival. A single center retrospective study.

Authors:  Cinzia Rotondo; Addolorata Corrado; Daniela Cici; Stefano Berardi; Francesco Paolo Cantatore
Journal:  Ther Adv Chronic Dis       Date:  2021-02-01       Impact factor: 5.091

5.  Significance of Anti-cyclic Citrullinated Peptide Autoantibodies in Immune-mediated Inflammatory Skin Disorders with and without Arthritis.

Authors:  Chander Grover; Bineeta Kashyap; Deepashree Daulatabad; Amit Dhawan; Iqbal R Kaur
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.